Karuna Kumar: Busting the Myth about Increasing Infection Risk by IV Iron
Karuna Kumar, Senior Consultant at Yashoda Hospitals, shared a post on LinkedIn about a recent article by Paul W. Foley et al, published in European Journal of Heart Failure, adding:
“One concern I hear from colleagues about IV iron:
‘Doesn’t it increase infection risk? Iron feeds bacteria.’
Fair question. The theory makes sense. Iron is essential for bacterial growth. Give IV iron, maybe you’re feeding pathogens.
The IRONMAN trial just addressed this directly.
They looked at heart failure patients who received IV ferric derisomaltose vs standard care. Specifically tracked serious infections.
The finding?
No increased infection risk.
In fact, there was a trend toward fewer infections in the IV iron group. Not statistically significant, but certainly not worse.
The explanation:
Correcting iron deficiency actually improves immune function. Iron-deficient patients are more susceptible to infections, not less.
My practice hasn’t changed. I’ve been comfortable with IV iron for years. But now I have better data to share with patients who ask.
Based on current evidence, the infection concern appears to be theoretical rather than clinical. More data from other populations will help confirm.
Source:
Eur J Heart Fail 2025 (IRONMAN trial)”
Title: Effect of Correcting Iron Deficiency on the Risk of Serious Infection in Heart Failure: Insights from the IRONMAN Trial
Authors: Paul W. Foley, Paul R. Kalra, John G.F. Cleland, Mark C. Petrie, Philip A. Kalra, Ian Squire, Philip Campbell, Callum Chapman, Patrick Donnelly, Fraser Graham, Andrew Hannah, Ninian N. Lang, Iain Matthews, Stephen J. Leslie, Pierpaolo Pellicori, Sue Piper, Robin Ray, Hernry O. Savage, Chales Spencer, John Walsh, Yuk-Ki Wong, Ian Ford
Stay updated with Hemostasis Today.
-
Sep 22, 2026, 03:05Sumyea Kabir: Jehovah’s Witnesses Update Their Position on Blood Components
-
Sep 22, 2026, 02:33Gerardo Moscatelli: The Spike Protein Cascade – From Endothelial Binding to Vascular Collapse
-
Sep 21, 2026, 20:56George Touma: ApoB Should Be Central to All Lipid Guidlines
-
Sep 21, 2026, 20:55Christopher Robinson: Obstetric Risks Are Seen at the Extremes of Birthweight
-
Sep 21, 2026, 20:54Emicizumab for Refractory GI Bleeding in Myeloma-Associated Acquired VWD – JTH
-
Sep 21, 2026, 20:52Ross Baker: ASH 2026 Guidelines on Iron Deficiency in HMB and Bleeding Disorders
-
Sep 21, 2026, 20:50Rainer Kaiser: Genes and Signalling Pathways Implicated in Procoagulant Platelet Generation
-
Sep 21, 2026, 20:49Natalia Dovlatova: Celebrating Stan Heptinstall and His Legacy in Platelet Science
-
Sep 21, 2026, 20:48Norm Roulet: The Interaction of Pb and SARS-CoV-2 and Its Impact on the Cardiovascular System